• Mayank Aranke, Roya Moheimani, Melissa Phuphanich, Alan D Kaye, Anh L Ngo, Omar Viswanath, and Jared Herman.
• Department of Anesthesiology, University of Texas Health Science Center, Houston, TX, USA.
• Curr Pain Headache Rep. 2021 Mar 11; 25 (4): 2121.

Purpose Of ReviewThis review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review's goal is to add to the body of literature available on this topic and give interventional providers and practitioners an additional resource to consider when performing procedures.Recent FindingsIn the current SARS-CoV2 epidemiological environment, infection control and costs associated with healthcare-associated infections (HAIs) are of paramount importance. Even before the onset of SARS-CoV2, HAIs affected nearly 2million patients a year in the USA and resulted in nearly 90,000 deaths, all of which resulted in a cost to hospitals ranging from US$28 billion to 45 billion. The onset SARS-CoV2, though not spread by an airborne route, has heightened infection control protocols in hospitals and, as such, cast a renewed focus on disinfectants and their utility across different settings and organisms. The aim of this review is to provide a comprehensive overview of disinfectants used in the inpatient setting.

21 keywords...

hide…